| Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system YP de Coaña, A Choudhury, R Kiessling Trends in molecular medicine 21 (8), 482-491, 2015 | 200 | 2015 |
| Melanoma-Educated CD14+ Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2–Dependent Mechanisms Y Mao, I Poschke, E Wennerberg, YP de Coaña, SE Brage, I Schultz, ... Cancer research 73 (13), 3877-3887, 2013 | 188 | 2013 |
| Ipilimumab treatment results in an early decrease in the frequency of circulating granulocytic myeloid-derived suppressor cells as well as their Arginase1 production YP de Coaña, I Poschke, G Gentilcore, Y Mao, M Nyström, J Hansson, ... Cancer immunology research 1 (3), 158-162, 2013 | 133 | 2013 |
| Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma YP de Coaña, M Wolodarski, I Poschke, Y Yoshimoto, Y Yang, M Nyström, ... Oncotarget 8 (13), 21539, 2017 | 130 | 2017 |
| Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma YP de Coaña, M Wolodarski, I Poschke, Y Yoshimoto, Y Yang, M Nyström, ... Oncotarget 8 (13), 21539, 2017 | 130 | 2017 |
| Counteracting CAR T cell dysfunction M Poorebrahim, J Melief, YP de Coaña, SL Wickström, A Cid-Arregui, ... Oncogene 40 (2), 421-435, 2021 | 100 | 2021 |
| IL-15, TIM-3 and NK cells subsets predict responsiveness to anti-CTLA-4 treatment in melanoma patients R Tallerico, CM Cristiani, E Staaf, C Garofalo, R Sottile, M Capone, ... Oncoimmunology 6 (2), e1261242, 2017 | 64 | 2017 |
| IL-15, TIM-3 and NK cells subsets predict responsiveness to anti-CTLA-4 treatment in melanoma patients R Tallerico, CM Cristiani, E Staaf, C Garofalo, R Sottile, M Capone, ... OncoImmunology 6 (2), e1261242, 2017 | 64 | 2017 |
| A highly infective Plasmodium vivax strain adapted to Aotus monkeys: quantitative haematological and molecular determinations useful for P. vivax malaria vaccine development YP De Coaña, J Rodrıguez, E Guerrero, C Barrero, R Rodrıguez, ... Vaccine 21 (25-26), 3930-3937, 2003 | 53 | 2003 |
| Interactions among myeloid regulatory cells in cancer V Umansky, GJ Adema, J Baran, S Brandau, JA Van Ginderachter, X Hu, ... Cancer Immunology, Immunotherapy, 1-16, 2018 | 51 | 2018 |
| Self-Delivering RNAi Targeting PD-1 Improves Tumor-Specific T Cell Functionality for Adoptive Cell Therapy of Malignant Melanoma MA Ligtenberg, YP de Coaña, T Shmushkovich, Y Yoshimoto, I Truxova, ... Molecular Therapy 26 (6), 1482-1493, 2018 | 41 | 2018 |
| PD-1 checkpoint blockade in advanced melanoma patients: NK cells, monocytic subsets and host PD-L1 expression as predictive biomarker candidates Y Pico de Coaña, M Wolodarski, I van der Haar Àvila, T Nakajima, ... OncoImmunology 9 (1), 1786888, 2020 | 36 | 2020 |
| In-depth plasma proteomics reveals increase in circulating PD-1 during anti-PD-1 immunotherapy in patients with metastatic cutaneous melanoma H Babačić, J Lehtiö, YP de Coaña, M Pernemalm, H Eriksson Journal for Immunotherapy of Cancer 8 (1), 2020 | 33 | 2020 |
| Myeloid-derived suppressor cells and their role in CTLA-4 blockade therapy YP De Coaña, G Masucci, J Hansson, R Kiessling Cancer Immunology, Immunotherapy 63 (9), 977-983, 2014 | 33 | 2014 |
| Molecular cloning and characterization of Cup a 4, a new allergen from Cupressus arizonica YP de Coaña, N Parody, MÁ Fuertes, J Carnés, D Roncarolo, R Ariano, ... Biochemical and biophysical research communications 401 (3), 451-457, 2010 | 31 | 2010 |
| A Modified Protocol for RNA Isolation from High Polysaccharide Containing Cupressus arizonica Pollen. Applications for RT–PCR and Phage Display Library … YP De Coaña, N Parody, E Fernández-Caldas, C Alonso Molecular biotechnology 44 (2), 127-132, 2010 | 15 | 2010 |
| Melanoma and immunotherapy bridge 2015: Naples, Italy. 1–5 December 2015 VGY Nanda, W Peng, P Hwu, MA Davies, G Ciliberto, L Fattore, ... Journal of Translational Medicine 14, 1-27, 2016 | 13 | 2016 |
| Quantifying Aotus monkey cytokines by real-time quantitative RT-PCR YP de Coaña, C Barrero, I Cajiao, C Mosquera, ME Patarroyo, ... Cytokine 27 (4-5), 129-133, 2004 | 13 | 2004 |
| Predicting anti-PD-1 responders in malignant melanoma from the frequency of S100A9+ monocytes in the blood. S Rad Pour, Y Pico de Coaña, XM Demorentin, J Melief, M Thimma, ... BMJ, 2021 | 11 | 2021 |
| Predicting anti-PD-1 responders in malignant melanoma from the frequency of S100A9+ monocytes in the blood SR Pour, YP de Coaña, XM Demorentin, J Melief, M Thimma, ... Journal for immunotherapy of cancer 9 (5), 2021 | 11 | 2021 |
